The aim of this study is to develop collimator inserts of various sizes whi
ch are either not commercially available or are expensive to import. The do
simetry parameters such as tissue maximum ratio (TMR), off-axis ratio (OAR)
and output factor of the developed collimator insert are compared with tha
t of the commercial collimator insert (Radionics). In order to check the su
itability of the collimator insert developed locally for clinical use and t
o standardize the method of development, a collimator insert of 15 mm ident
ical to the one supplied by Radionics is developed with low-melting alloy (
Cerrobend). Moreover for the clinical use of the developed collimator inser
t, certain acceptance tests are performed which include a collimator concen
tricity test, beam size check and radiation leakage test. The dose verifica
tion is carried out with a thermoluminescent dosimeter ((LiF)-Li-7 rods) an
d an FBX chemical dosimeter in a human-head-shaped Perspex phantom filled w
ith water. The variation between the calculated and measured dose is found
to be within +2.4% for (LiF)-Li-7 rods and -2.0% for the FBX chemical dosim
eter thus ensuring the suitability of the developed collimator insert for c
linical use. This has encouraged us to standardize the method adapted to de
velop the collimator insert and to develop collimator inserts of different
field sizes.